[The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
D003911:Dextrans / Q000494:pharmacology*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000494:pharmacology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000628:therapy; D010953:Plasma Volume / Q000187:drug effects*; D011097:Polygeline / Q000494:pharmacology*; D011108:Polymers / Q000494:pharmacology*; D006435:Renal Dialysis; D013213:Starch / Q000031:analogs & derivatives*; D013997:Time Factors
D003911:Dextrans; D006895:Hydroxyethyl Starch Derivatives; D011108:Polymers; D013213:Starch; D011097:Polygeline
Die Volumenwirkung von 6% Hydroxyäthylstärke 450/0,7, 10% Dextran 40 und 3,5% isozyanatvernetzter Gelatine bei Patienten mit terminaler Niereninsuffizienz.